Arvin Jonathan Olegario Sioc, MSN, FNP-BC
Family · Hollister
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Arvin Jonathan Olegario Sioc’s office at (831) 636-1507 to ask if they take your plan before you enroll.
Medicaid work
$1,294 in 2023
Medicaid paid $1,294 for 160 billed services this clinician did in 2023, up to 66 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 144 | $1,207 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 16 | $87 |
| 2023 | 160 | 2 | 66 | $1,294 |
| 2022 | 196 | 2 | 45 | $600 |
See the largest Medicaid services in earlier years
2022
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 178 | $600 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 18 | $0 |
Drugs they prescribed that Part D paid
$30,825
Pharmacies billed $30,825 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (25 of 472) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
396 generic and fewer than 11 brand-name prescriptions · $30,825 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 12 | $13,594 | $1,133 |
| Levothyroxine | 49 | $671 | $14 |
| Oxycodone-Acetaminophen | 17 | $350 | $21 |
| Albuterol Sulfate Hfa | 18 | $337 | $19 |
| Atorvastatin | 16 | $182 | $11 |
See all 7 drugs
| Eliquis | 12 | $13,594 | $1,133 |
| Levothyroxine | 49 | $671 | $14 |
| Oxycodone-Acetaminophen | 17 | $350 | $21 |
| Albuterol Sulfate Hfa | 18 | $337 | $19 |
| Atorvastatin | 16 | $182 | $11 |
| Losartan | 13 | $161 | $12 |
| Amlodipine Besylate | 12 | $153 | $13 |
Year by year
| 2024 | 472 | 117 | 5% (25) | None | $30,825 |
| 2023 | 94 | 28 | 14% (13) | None | $14,221 |
| 2022 | 49 | 24 | None | None | $12,649 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Eliquis | 12 | $3,369 | $281 |
Money from drug and device companies
$406 in 2025
| 2025 | 7 | 25 | None | $406 |
| 2024 | 11 | 52 | None | $997 |
| 2023 | 13 | 49 | None | $888 |
| 2022 | 13 | 22 | None | $454 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $213 | 5 payments
|
| Pfizer | Eliquis | $70 | 3 payments
|
| Novo Nordisk | Rybelsus | $28 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $27 | 1 payment
|
| Lilly USA | Mounjaro | $25 | 1 payment
|
| Kowa Pharmaceuticals America | Zoryve | $22 | 1 payment
|
See all 13 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-12 | Airsupra | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-07 | Breztri | $25 |
| Novo Nordisk | Meals · 2025-10-30 | Rybelsus | $28 |
| Pfizer | Meals · 2025-10-24 | Paxlovid | $25 |
| Lilly USA | Meals · 2025-10-10 | Mounjaro | $25 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-19 | Jardiance | $27 |
| Pfizer | Meals · 2025-05-19 | Eliquis | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-08 | None | $16 |
| Kowa Pharmaceuticals America | Meals · 2025-04-18 | Zoryve | $22 |
| Amgen | Meals · 2025-03-28 | Otezla | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-21 | None | $23 |
| Pfizer | Meals · 2025-02-07 | Eliquis | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-08 | Airsupra | $135 |
See earlier years (2024, 2023, 2022)
2024: $997
| AstraZeneca Pharmaceuticals LP | Farxiga | $356 | 15 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $178 | 8 payments
|
| Novo Nordisk | Ozempic | $92 | 4 payments
|
| Abbvie | Vraylar | $92 | 4 payments
|
| Pfizer | Nurtec Odt | $89 | 4 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $78 | 3 payments
|
| Amgen | Otezla | $31 | 1 payment
|
| Otsuka America Pharmaceutical | Nuedexta | $26 | 1 payment
|
| Shield Therapeutics | Accrufer | $20 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $19 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $16 | 1 payment
|
2023: $888
| Abbvie | Vraylar | $192 | 15 payments
|
| Pfizer | Eliquis | $127 | 7 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $109 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $101 | 5 payments
|
| Novo Nordisk | Ozempic | $89 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $62 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $51 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $34 | 2 payments
|
| Amgen | Otezla | $34 | 2 payments
|
| Lilly USA | Jardiance | $27 | 1 payment
|
| Sanofi-Aventis U.S. | Tzield | $26 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $20 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $17 | 1 payment
|
2022: $454
| Merck Sharp & Dohme | Januvia | $134 | 6 payments
|
| Novo Nordisk | Saxenda | $68 | 3 payments
|
| Amarin Pharma | Vascepa | $47 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $35 | 2 payments
|
| Mylan Specialty L.P. | Yupelri | $24 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $23 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $22 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $18 | 1 payment
|
| Pfizer | Eucrisa | $18 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $16 | 1 payment
|
| RedHill Biopharma | Talicia | $16 | 1 payment
|
| Lilly USA | None | $12 | 1 payment
|
Professional record
- NPI
- 1922769363
- Licence
- CA 95019660
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 867 Camrose Ct, Gilroy, CA, 95020
- NPI first listed
- 2022-01-07
- NPI last updated
- 2022-03-30
- NPI record certified
- 2022-03-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 867 Camrose Ct, Gilroy, CA, 95020